Rapport Therapeutics Inc (RAPP)
R&D Expense Growth
55.56%
Fiscal year · Period ending:
RAPP R&D Expense Growth
Latest reported55.56%period ending
Latest reported55.56%period ending
RAPP FY R&D Growth (YoY) (0.00% → 55.56%)
Latest values, visible window
High-resolution chart · PNG
RAPP r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 55.5576% | |
| 117.6328% | |
| 207.175% | |
| 0% |